Last updated at 29 Oct 2025 08:56 AM
Director
DIN: 00403635
Devang Narendra Shah is currently associated with 3 companies in various capacities such as Director and Individual Subscriber. They serve as a Director at HADES SOLUTIONS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 00403635.Devang Narendra Shah is currently involved in 2 different roles. Their most recent position is with CISB DPB PHARMACEUTICALS PRIVATE LIMITED as a Individual Subscriber. The first company Devang Narendra Shah was appointed to as a director was HADES SOLUTIONS PRIVATE LIMITED. Devang Narendra Shah is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Devang Narendra Shah is currently associated with 3 companies in various capacities such as Director and Individual Subscriber. They serve as a Director at HADES SOLUTIONS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 00403635.Devang Narendra Shah is currently involved in 2 different roles. Their most recent position is with CISB DPB PHARMACEUTICALS PRIVATE LIMITED as a Individual Subscriber. The first company Devang Narendra Shah was appointed to as a director was HADES SOLUTIONS PRIVATE LIMITED. Devang Narendra Shah is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
3
Male
India
Gain instant access to verified contact details.
Current Companies (3)
Current LLPs (0)
Past Companies (0)
4 Years 2 Years Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| HADES SOLUTIONS PRIVATE LIMITED | Director | 01-Apr-2006 |
| END TO END OUTSOURCING SOLUTION PRIVATE LIMITED | Director | 30-Sep-2010 |
| CISB DPB PHARMACEUTICALS PRIVATE LIMITED | Individual Subscriber | 17-Jun-2025 |